Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001437749-17-003451
Filing Date
2017-03-01
Accepted
2017-02-28 19:04:03
Documents
100
Period of Report
2016-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K oxfd20161231_10k.htm 10-K 2825842
2 EXHIBIT 10.20 ex10-20.htm EX-10.20 18566
3 EXHIBIT 21.1 ex21-1.htm EX-21.1 8235
4 EXHIBIT 23.1 ex23-1.htm EX-23.1 6197
5 EXHIBIT 31.1 ex31-1.htm EX-31.1 14649
6 EXHIBIT 31.2 ex31-2.htm EX-31.2 14684
7 EXHIBIT 32 ex32.htm EX-32 6835
14 a1.jpg GRAPHIC 62101
  Complete submission text file 0001437749-17-003451.txt   10903239

Data Files

Seq Description Document Type Size
8 EXHIBIT 101.INS oxfd-20161231.xml EX-101.INS 2109274
9 EXHIBIT 101.SCH oxfd-20161231.xsd EX-101.SCH 91487
10 EXHIBIT 101.CAL oxfd-20161231_cal.xml EX-101.CAL 76895
11 EXHIBIT 101.DEF oxfd-20161231_def.xml EX-101.DEF 687682
12 EXHIBIT 101.LAB oxfd-20161231_lab.xml EX-101.LAB 568900
13 EXHIBIT 101.PRE oxfd-20161231_pre.xml EX-101.PRE 722884
Mailing Address 94C INNOVATION DRIVE MILTON PARK ABINGDON X0 OX14 4RZ
Business Address 94C INNOVATION DRIVE MILTON PARK ABINGDON X0 OX14 4RZ 44 01235 442780
Oxford Immunotec Global PLC (Filer) CIK: 0001586049 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-36200 | Film No.: 17650582
SIC: 2835 In Vitro & In Vivo Diagnostic Substances